Skip to main content

Peer Review reports

From: ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma

Original Submission
28 Dec 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
1 Feb 2023 Reviewed Reviewer Report
13 Feb 2023 Reviewed Reviewer Report - Seyedehsahar Mortazavifarsani
26 Feb 2023 Author responded Author comments - Xiangcheng Li
Resubmission - Version 3
26 Feb 2023 Submitted Manuscript version 3
4 Mar 2023 Author responded Author comments - Xiangcheng Li
Resubmission - Version 4
4 Mar 2023 Submitted Manuscript version 4
9 Mar 2023 Author responded Author comments - Xiangcheng Li
Resubmission - Version 5
9 Mar 2023 Submitted Manuscript version 5
27 Mar 2023 Reviewed Reviewer Report - Seyedehsahar Mortazavifarsani
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
28 Apr 2023 Editorially accepted
16 May 2023 Article published 10.1186/s12885-023-10903-5

You can find further information about peer review here.

Back to article page